 |
|
|
|
|
Washington Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing WashingtonLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
CTI BioPharma Corp.
| | | | | Phone: | (206) 282-7100 | | Fax: | (206) 284-6206 | | Year Established: | 1991 | | Employees: | 125 | | Ticker: | CTIC | | Exchange: | NASDAQ | | Main Contact: | Adam R. Craig, M.D., Ph.D., President & CEO | | | | Other Contacts: | David H. Kirske, Executive VP & CFO
Jack W. Singer, M.D., EVP, CSO & Interim CMO
Bruce J. Seeley, Executive VP & COO
| | | | Company Description | | CTI BioPharma (formerly Cell Therapeutics) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. The CTI BioPharma lead product candidate, pacritinib, is being developed for the treatment of patients with myelofibrosis. | |
|
|
|
|
|
|
|
